Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA4752382
Max Phase: Preclinical
Molecular Formula: C54H98N24O11
Molecular Weight: 1259.53
Molecule Type: Unknown
Associated Items:
ID: ALA4752382
Max Phase: Preclinical
Molecular Formula: C54H98N24O11
Molecular Weight: 1259.53
Molecule Type: Unknown
Associated Items:
Canonical SMILES: CC(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(N)=O)[C@@H](C)O
Standard InChI: InChI=1S/C54H98N24O11/c1-30(70-44(83)34(71-32(3)80)19-11-25-66-51(58)59)43(82)72-37(20-12-26-67-52(60)61)48(87)77-40(29-33-15-5-4-6-16-33)50(89)76-38(21-13-27-68-53(62)63)47(86)74-35(17-7-9-23-55)45(84)73-36(18-8-10-24-56)46(85)75-39(22-14-28-69-54(64)65)49(88)78-41(31(2)79)42(57)81/h4-6,15-16,30-31,34-41,79H,7-14,17-29,55-56H2,1-3H3,(H2,57,81)(H,70,83)(H,71,80)(H,72,82)(H,73,84)(H,74,86)(H,75,85)(H,76,89)(H,77,87)(H,78,88)(H4,58,59,66)(H4,60,61,67)(H4,62,63,68)(H4,64,65,69)/t30-,31+,34-,35-,36-,37-,38-,39-,40-,41-/m0/s1
Standard InChI Key: NPEJVWKBLYRDOM-DBQPWCSESA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 1259.53 | Molecular Weight (Monoisotopic): 1258.7847 | AlogP: | #Rotatable Bonds: |
Polar Surface Area: | Molecular Species: | HBA: | HBD: |
#RO5 Violations: | HBA (Lipinski): | HBD (Lipinski): | #RO5 Violations (Lipinski): |
CX Acidic pKa: | CX Basic pKa: | CX LogP: | CX LogD: |
Aromatic Rings: | Heavy Atoms: | QED Weighted: | Np Likeness Score: |
1. Lewandowska-Goch MA,Kwiatkowska A,Łepek T,Ly K,Navals P,Gagnon H,Dory YL,Prahl A,Day R. (2021) Design and Structure-Activity Relationship of a Potent Furin Inhibitor Derived from Influenza Hemagglutinin., 12 (3): [PMID:33738063] [10.1021/acsmedchemlett.0c00386] |
Source(1):